Yann started his internship in February 2024. His work is on identifying novel antifungal drug combinations that bypass drug resistance in pathogenic fungi.
Wu C, Gunnarsson EB, Myklebust EM, Köhn-Luque A, Tadele DS, Enserink JM, Frigessi A, Foo J, Leder K(2024) Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening data PLoS Comput Biol, 20(3), e1011888 DOI 10.1371/journal.pcbi.1011888, PubMed 38446830
Corrales J, Ramos-Alonso L, González-Sabín J, Ríos-Lombardía N, Trevijano-Contador N, Engen Berg H, Sved Skottvoll F, Moris F, Zaragoza O, Chymkowitch P, Garcia I, Enserink JM(2024) Characterization of a selective, iron-chelating antifungal compound that disrupts fungal metabolism and synergizes with fluconazole Microbiol Spectr, 12(2), e0259423 DOI 10.1128/spectrum.02594-23, PubMed 38230926
Andersen AN, Brodersen AM, Ayuda-Durán P, Piechaczyk L, Tadele DS, Baken L, Fredriksen J, Stoksflod M, Lenartova A, Fløisand Y, Skånland SS, Enserink JM(2023) Clinical forecasting of acute myeloid leukemia using ex vivo drug-sensitivity profiling Cell Rep Methods, 3(12), 100654 DOI 10.1016/j.crmeth.2023.100654, PubMed 38065095
Department of Molecular Cell Biology, Institute for Cancer Research The Norwegian Radium Hospital, Montebello, N-0379 Oslo, Norway Telephone +47 22 78 19 82 (Enserink), +47 22 78 12 69 (Dept. Secretary) Email: jorrit.enserink@rr-research.no
Yann started his internship in February 2024. His work is on identifying novel antifungal drug combinations that bypass drug resistance in pathogenic fungi.